Traitements antifongiques des candidémies chez les patients non neutropéniques : évaluation des pratiques en réanimation

Wisplinghoff, 2004, Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clin Infect Dis, 39, 309, 10.1086/421946 Horn, 2009, Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry, Clin Infect Dis, 15, 1695, 10.1086/599039 Dizbay M, Fidan I, Kalkanci A, Sari N, Yalcin B, Kustimur S, et al. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility. Scand J Infect Dis 2010;42:114–20. Gauzit, 2003, Infections by Candida sp. in intensive care. Survey of French practices, Presse Med, 32, 440 Gudlaugsson, 2003, Attributable mortality of nosocomial candidemia, revisited, Clin Infect Dis, 37, 1172, 10.1086/378745 Morgan, 2005, Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance, Infect Control Hosp Epidemiol, 26, 540, 10.1086/502581 Boucher, 2004, Newer systemic antifungal agents: pharmacokinetics, safety and efficacy, Drugs, 64, 1997, 10.2165/00003495-200464180-00001 Prise en charge des aspergilloses et candidoses invasives de l’adulte. Conférence de consensus commune SFAR, SPILF, SRLF. Reanimation 2004;13:5–13. Herbrecht R, Flückiger U, Gachot B, Ribaud P, Thiebaut A, Cordonnier C. Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients. Eur J Cancer Supplements 2007;5:49–59. Le Gall, 1993, A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study, JAMA, 270, 2957, 10.1001/jama.1993.03510240069035 Vincent, 1996, The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure, Intensive Care Med, 22, 707, 10.1007/BF01709751 Leroy, 2009, Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006), Crit Care Med, 37, 1612, 10.1097/CCM.0b013e31819efac0 Leroy, 2008, Invasive candidiasis in ICU: analysis of antifungal treatments in the French study AmarCand, Ann Fr Anesth Reanim, 27, 999, 10.1016/j.annfar.2008.10.004 Charles, 2003, Candidemia in critically ill patients: difference of outcome between medical and surgical patients, Intensive Care Med, 29, 2162, 10.1007/s00134-003-2002-x Nolla-Salas, 1997, Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU, Intensive Care Med, 23, 23, 10.1007/s001340050286 Edmond, 1999, Nosocomial bloodstream infections in United States hospitals: a three-year analysis, Clin Infect Dis, 29, 239, 10.1086/520192 León, 2009, Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study, Eur J Clin Microbiol Infect Dis, 28, 233, 10.1007/s10096-008-0618-z Pappas, 2009, Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America, Clin Infect Dis, 48, 503, 10.1086/596757